Please assess the completion status of the following clinical trial:

Trial Title: Evaluation and Treatment of Copper/Zinc Imbalance in Children With Autism

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Ages 3-8 years~* Diagnosis of autism spectrum disorder~* Serum copper/zinc ratio greater than 2.0 or as determined in phase 1 of the study~Exclusion Criteria:~* Known chromosomal disorder or neurological disorders other than autism

- Gender: ALL
- Minimum Age: 3 Years
- Maximum Age: 8 Years
- Healthy Volunteers: t

Study Arms:
- Oral zinc and vitamin C supplementation (Type: ACTIVE_COMPARATOR): Participant will receive oral zinc and vitamin C supplementation based on the child's weight. Blood levels of zinc, copper, liver and renal function as well as blood counts will be measured. Copper to zinc ratio will be calculated at 6 and 16 weeks
- Oral Placebo (Type: PLACEBO_COMPARATOR): Participant will receive placebo liquid with volume based on child's weight to match the amount given to participants in the experimental group.

Based on this trial design, predict the completion outcome and termination type (if applicable).